[ET Net News Agency, 25 August 2026] HENGRUI PHARMA (01276) fell 1% to HK$46.
It hits an intra-day low of HK$46, hitting a historical low, and an intra-day high of HK$46.76. The total shares traded was 2.56 million, with a value of HK$119.1m. The active buy/sell ratio is 55:45, with net buying turnover of HK$10.91m. MERRILL LYNCH FE accounts for greatest net responsive buying turnover of HK$7.02m, with volume weighted average price of HK$46.456. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$14.99m, with volume weighted average price of HK$46.492. The stock has fallen a combined 16.3% over the past 4 consecutive trading days.
Basic Information| Nominal | 46.000 | % Chg | -0.99% |
| High | 46.760 | Low | 46.000 |
| Shares Tr | 2.56m | Turnover | 119.1m |
| 10-D SMA | 51.692 | %H.V | 47.172 |
| 20-D SMA | 54.641 | VWAP | 46.460 |
| 50-D SMA | 56.158 | RSI14 | 25.770 |
Status: Hitting a historical low, active buy/sell ratio is 55:45, with net buying turnover of HK$10.91m, falling a combined 16.3% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HENGRUI PHARMA (01276) | 46.00 | -0.99 |
| GRAND PHARMA (00512) | 5.18 | -0.96 |
| SBP GROUP (01177) | 5.52 | -1.08 |
| LIVZON PHARMA (01513) | 20.28 | -3.43 |
| LUYE PHARMA (02186) | 2.11 | +0.24 |
| FOSUN PHARMA (02196) | 16.87 | +0.42 |
| UNI HEALTH (02211) | 0.70 | -9.09 |
| SH PHARMA (02607) | 11.45 | -0.61 |
| CHINARES PHARMA (03320) | 4.63 | -1.59 |
| HANSOH PHARMA (03692) | 31.00 | -0.19 |
(ed)
